Global Hydroxyprogesterone Caproate Injection Competitive Landscape Professional Research Report 2025
Research Summary
Hydroxyprogesterone Caproate Injection is a medication used in obstetrics and gynecology to help reduce the risk of preterm birth in certain pregnant individuals. It is a synthetic form of the hormone progesterone and is administered as an intramuscular injection. Hydroxyprogesterone caproate is typically prescribed to pregnant individuals with a history of preterm birth, providing supplemental progesterone support to help maintain the uterine environment and reduce the likelihood of premature delivery. The injection is usually given weekly during the second half of pregnancy. While hydroxyprogesterone caproate has been shown to be effective in some cases, its use is subject to careful medical evaluation, and decisions regarding its administration are made on an individual basis, taking into account the specific circumstances and medical history of the pregnant individual.
According to DIResearch's in-depth investigation and research, the global Hydroxyprogesterone Caproate Injection market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Hydroxyprogesterone Caproate Injection include AMAG Pharmaceuticals, Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Mylan Institutional etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Hydroxyprogesterone Caproate Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hydroxyprogesterone Caproate Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Hydroxyprogesterone Caproate Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hydroxyprogesterone Caproate Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Hydroxyprogesterone Caproate Injection Include:
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent
Mylan Institutional
Hydroxyprogesterone Caproate Injection Product Segment Include:
1 mL Injection(Including 1.1 mL)
5 mL Injection
Hydroxyprogesterone Caproate Injection Product Application Include:
Hospitals Injection
Clinics Injection
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Hydroxyprogesterone Caproate Injection Industry PESTEL Analysis
Chapter 3: Global Hydroxyprogesterone Caproate Injection Industry Porter’s Five Forces Analysis
Chapter 4: Global Hydroxyprogesterone Caproate Injection Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Hydroxyprogesterone Caproate Injection Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Hydroxyprogesterone Caproate Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Hydroxyprogesterone Caproate Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Hydroxyprogesterone Caproate Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Hydroxyprogesterone Caproate Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Hydroxyprogesterone Caproate Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Hydroxyprogesterone Caproate Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Hydroxyprogesterone Caproate Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Hydroxyprogesterone Caproate Injection Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Hydroxyprogesterone Caproate Injection Product by Type
- 1.2.1 1 mL Injection(Including 1.1 mL)
- 1.2.2 5 mL Injection
- 1.3 Hydroxyprogesterone Caproate Injection Product by Application
- 1.3.1 Hospitals Injection
- 1.3.2 Clinics Injection
- 1.4 Global Hydroxyprogesterone Caproate Injection Market Revenue and Sales Analysis
- 1.4.1 Global Hydroxyprogesterone Caproate Injection Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Hydroxyprogesterone Caproate Injection Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Hydroxyprogesterone Caproate Injection Market Sales Price Trend Analysis (2020-2032)
- 1.5 Hydroxyprogesterone Caproate Injection Industry Trends and Innovation
- 1.5.1 Hydroxyprogesterone Caproate Injection Industry Trends and Innovation
- 1.5.2 Hydroxyprogesterone Caproate Injection Market Drivers and Challenges
- 2 Hydroxyprogesterone Caproate Injection Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Hydroxyprogesterone Caproate Injection Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Hydroxyprogesterone Caproate Injection Market Analysis by Regions
- 4.1 Hydroxyprogesterone Caproate Injection Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Hydroxyprogesterone Caproate Injection Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Hydroxyprogesterone Caproate Injection Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Hydroxyprogesterone Caproate Injection Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Region (2026-2032)
- 4.4 Global Hydroxyprogesterone Caproate Injection Sales Price Trend Analysis (2020-2032)
- 5 Global Hydroxyprogesterone Caproate Injection Market Size by Type and Application
- 5.1 Global Hydroxyprogesterone Caproate Injection Market Size by Type
- 5.1.1 Global Hydroxyprogesterone Caproate Injection Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Hydroxyprogesterone Caproate Injection Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Hydroxyprogesterone Caproate Injection Market Size by Application
- 5.2.1 Global Hydroxyprogesterone Caproate Injection Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Hydroxyprogesterone Caproate Injection Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Hydroxyprogesterone Caproate Injection Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Hydroxyprogesterone Caproate Injection Market Size by Type
- 6.3.1 North America Hydroxyprogesterone Caproate Injection Sales by Type (2020-2032)
- 6.3.2 North America Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2032)
- 6.4 North America Hydroxyprogesterone Caproate Injection Market Size by Application
- 6.4.1 North America Hydroxyprogesterone Caproate Injection Sales by Application (2020-2032)
- 6.4.2 North America Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2032)
- 6.5 North America Hydroxyprogesterone Caproate Injection Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Hydroxyprogesterone Caproate Injection Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Hydroxyprogesterone Caproate Injection Market Size by Type
- 7.3.1 Europe Hydroxyprogesterone Caproate Injection Sales by Type (2020-2032)
- 7.3.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2032)
- 7.4 Europe Hydroxyprogesterone Caproate Injection Market Size by Application
- 7.4.1 Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2032)
- 7.4.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2032)
- 7.5 Europe Hydroxyprogesterone Caproate Injection Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Hydroxyprogesterone Caproate Injection Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Hydroxyprogesterone Caproate Injection Market Size by Type
- 8.3.1 China Hydroxyprogesterone Caproate Injection Sales by Type (2020-2032)
- 8.3.2 China Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2032)
- 8.4 China Hydroxyprogesterone Caproate Injection Market Size by Application
- 8.4.1 China Hydroxyprogesterone Caproate Injection Sales by Application (2020-2032)
- 8.4.2 China Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Hydroxyprogesterone Caproate Injection Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Hydroxyprogesterone Caproate Injection Market Size by Type
- 9.3.1 APAC (excl. China) Hydroxyprogesterone Caproate Injection Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Hydroxyprogesterone Caproate Injection Market Size by Application
- 9.4.1 APAC (excl. China) Hydroxyprogesterone Caproate Injection Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Hydroxyprogesterone Caproate Injection Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Hydroxyprogesterone Caproate Injection Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Hydroxyprogesterone Caproate Injection Market Size by Type
- 10.3.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Type (2020-2032)
- 10.3.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2032)
- 10.4 Latin America Hydroxyprogesterone Caproate Injection Market Size by Application
- 10.4.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Application (2020-2032)
- 10.4.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2032)
- 10.5 Latin America Hydroxyprogesterone Caproate Injection Market Size by Country
- 10.6 Latin America Hydroxyprogesterone Caproate Injection Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Hydroxyprogesterone Caproate Injection Market Size by Type
- 11.3.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Hydroxyprogesterone Caproate Injection Market Size by Application
- 11.4.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2032)
- 11.5 Middle East Hydroxyprogesterone Caproate Injection Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Hydroxyprogesterone Caproate Injection Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Hydroxyprogesterone Caproate Injection Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Hydroxyprogesterone Caproate Injection Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Hydroxyprogesterone Caproate Injection Average Sales Price by Manufacturers (2021-2025)
- 12.2 Hydroxyprogesterone Caproate Injection Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Hydroxyprogesterone Caproate Injection Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 AMAG Pharmaceuticals
- 13.1.1 AMAG Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
- 13.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Mcguff Pharmaceuticals Inc
- 13.2.1 Mcguff Pharmaceuticals Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
- 13.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Aspen Oss B.V
- 13.3.1 Aspen Oss B.V Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
- 13.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 American Regent
- 13.4.1 American Regent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 American Regent Hydroxyprogesterone Caproate Injection Product Portfolio
- 13.4.3 American Regent Hydroxyprogesterone Caproate Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Mylan Institutional
- 13.5.1 Mylan Institutional Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
- 13.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Hydroxyprogesterone Caproate Injection Industry Chain Analysis
- 14.2 Hydroxyprogesterone Caproate Injection Industry Raw Material and Suppliers Analysis
- 14.2.1 Hydroxyprogesterone Caproate Injection Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Hydroxyprogesterone Caproate Injection Typical Downstream Customers
- 14.4 Hydroxyprogesterone Caproate Injection Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook